Biogen Inc (BIIB)
157.87
+1.87
(+1.20%)
USD |
NASDAQ |
Nov 21, 16:00
158.04
+0.17
(+0.11%)
After-Hours: 17:45
Biogen Debt to Equity Ratio: 0.3847 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.3847 |
| June 30, 2024 | 0.396 |
| March 31, 2024 | 0.4299 |
| December 31, 2023 | 0.4688 |
| September 30, 2023 | 0.5031 |
| June 30, 2023 | 0.4344 |
| March 31, 2023 | 0.4554 |
| December 31, 2022 | 0.4688 |
| September 30, 2022 | 0.4915 |
| June 30, 2022 | 0.6129 |
| March 31, 2022 | 0.6471 |
| December 31, 2021 | 0.6675 |
| September 30, 2021 | 0.6971 |
| June 30, 2021 | 0.6761 |
| March 31, 2021 | 0.6803 |
| December 31, 2020 | 0.694 |
| September 30, 2020 | 0.6902 |
| June 30, 2020 | 0.6565 |
| March 31, 2020 | 0.4752 |
| December 31, 2019 | 0.4463 |
| September 30, 2019 | 0.4254 |
| June 30, 2019 | 0.4592 |
| March 31, 2019 | 0.4297 |
| December 31, 2018 | 0.4553 |
| September 30, 2018 | 0.4308 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.4835 |
| March 31, 2018 | 0.4221 |
| December 31, 2017 | 0.4708 |
| September 30, 2017 | 0.5063 |
| June 30, 2017 | 0.5623 |
| March 31, 2017 | 0.5675 |
| December 31, 2016 | 0.5368 |
| September 30, 2016 | 0.5393 |
| June 30, 2016 | 0.5738 |
| March 31, 2016 | 0.6334 |
| December 31, 2015 | 0.6963 |
| September 30, 2015 | 0.618 |
| June 30, 2015 | 0.0461 |
| March 31, 2015 | 0.0501 |
| December 31, 2014 | 0.054 |
| September 30, 2014 | 0.0563 |
| June 30, 2014 | 0.0617 |
| March 31, 2014 | 0.0651 |
| December 31, 2013 | 0.0691 |
| September 30, 2013 | 0.0859 |
| June 30, 2013 | 0.0923 |
| March 31, 2013 | 0.1247 |
| December 31, 2012 | 0.1639 |
| September 30, 2012 | 0.1669 |
| June 30, 2012 | 0.1746 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3847
Minimum
Sep 2024
0.6971
Maximum
Sep 2021
0.5488
Average
0.4973
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.185 |
| Sage Therapeutics Inc | 0.00 |
| Pfizer Inc | 0.7219 |
| Amgen Inc | 8.024 |
| Ionis Pharmaceuticals Inc | 1.930 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 28.31B |
| Total Liabilities (Quarterly) | 11.95B |
| Shareholders Equity (Quarterly) | 16.36B |
| Current Ratio | 1.259 |
| Net Debt Paydown Yield | -0.01% |